Breaking News Headlines Today | Ground News

See every side of every news story

PharmaVOICE image

News from PharmaVOICE

Your destination for news from PharmaVOICE. See how PharmaVOICE’s media bias impacts the breaking news stories of today.

In total, 69 have been published by PharmaVOICE which Ground News has aggregated in the past 3 months.

The Ground News media bias check for PharmaVOICE is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

PharmaVOICE’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about PharmaVOICE

Where is PharmaVOICE located?PharmaVOICE's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byMedia Bias/Fact Check

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top PharmaVOICE News

The US Is Having Its Worst Year for Measles in More than 30 Years

Measles Outbreak · United States

The US Is Having Its Worst Year for Measles in More than 30 Years

54% Center coverage: 268 sources

The U.S. is experiencing its worst measles outbreak in over three decades with 1,288 cases reported.See the Story

CRLs Are the Low-Hanging Fruit of FDA Transparency, Experts Say

United States · United States

CRLs Are the Low-Hanging Fruit of FDA Transparency, Experts Say

100% Center coverage: 2 sources

(MedPage Today) -- FDA leaders claimed that publishing hundreds of complete response letters (CRLs) in a central database was embracing "radical transparency," but critics think the move was more about optics, and argue the agency has bigger transparency...See the Story

Novartis’ Zolgensma sales fall again as gene therapy market woes persist

Novartis’ Zolgensma sales fall again as gene therapy market woes persist

100% Center coverage: 1 sources

Novartis has seen sales decline in a difficult gene therapy market. Is there hope on the horizon?Read Article

Development of flexible assembly and packaging line to support clinical volumes of pens, autoinjectors and safety devices used for drug delivery

100% Center coverage: 1 sources

West’s new flexible line for pens and autoinjectors, launching Q1 2026, will streamline assembly, labeling, packaging and testing for clinical volumes and drive cost efficiency.Read Article

Closing the gap: How real-world data and artificial intelligence are reinventing the last mile of clinical research

100% Center coverage: 1 sources

Clinical trial delays are costly—here’s how RWD and AI are transforming recruitment and retention.Artificial Intelligence Read Article

FDA invites more data from abroad — with a wary eye on China

100% Center coverage: 1 sources

The FDA approved four drugs last year without any U.S. trial participants, but has maintained a tougher stance on China, even as it grows into an R&D powerhouse.United States · United States Read Article

Biotech IPO momentum gained steam last year, but market ‘turmoil’ has slowed the train again

100% Center coverage: 1 sources

The IPO market is a mixed bag in 2025, with some signs of life but several headwinds keeping activity relatively low.Read Article

Need a DTC platform? Here’s how one company built its own.

100% Center coverage: 1 sources

Currax Pharmaceuticals was ahead of the curve when it set up a direct access platform for its obesity med.United States · United States Read Article

Pricing watchdog will take on the rising cost of drugs at launch

100% Center coverage: 1 sources

ICER’s upcoming report could shed light on how the launch price of newly approved drugs affects overall cost and access from a patient perspective.United States · United States Read Article

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

100% Center coverage: 1 sources

Simone Steiner recently joined the French company to set the stage for launch.France · France Read Article

Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’

39% Left coverage: 74 sources

Trade War · United States See the Story

Breaking News Topics Related to PharmaVOICE